The extent to which hypothalamo-pituitary disorders in women affect sexual desire and sexual functions was investigated. Sexual functions and sexual appreciation were assessed in a comprehensive interview of 48 women with well-defined hypothalamo-pituitary disorders. Data about sex life were correlated to blood hormone levels and diagnosis. In most of the women (64.8%), the first clinical symptom indicating a hypothalamo-pituitary dysfunction began in the age group 16 to 35. In 43 patients (89.6%), the initial symptom was menstrual irregularities. Altogether 45 (93.8%) of the women declared that they had or had had significant sexual problems. Two of the three women who did not report sexual problems had never had intercourse. Thirty-eight (79.2%) of the women had developed a lack of or a considerable decrease in sexual desire. Problems with lubrication or orgasm were reported by 31 (64.6%) and 33 (68.7%) of the women, respectively. Normal menstrual pattern, young age, and intrasellar tumor growth correlated better with normal sexual desire and sexual functions than did normal prolactin levels and normal testosterone levels. However, at the time of interview, only 7 women had hyperprolactinemia. Serum testosterone values correlated significantly only with masturbation.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Abplanalp, J. M., Rose, R. M., Donnelly, A. F., and Livingston-Vaughan, L. (1979). Psychoendocrinology of the menstrual cycle: II. The relationship between enjoyment of activities, moods and reproductive hormones.Psychosom. Med. 41: 605–615.
Bakay, L. (1950). Results of 300 pituitary adenoma operations.J. Neurosurg. 7: 240–255.
Bancroft, J., Sanders, D., Davidson, D., and Warner, P. (1983). Mood, sexuality, hormones, and the menstrual cycle. III. Sexuality and the roles of androgens.Psychosom. Med. 45: 509–516.
Batzdorf, U., and Stern, W. E. (1973). Clinical manifestations of pituitary adenomas: A pilot study using computer analysis. In Koler, P. O., and Ross, G. T. (eds.),Pituitary Tumors Exerpta Medica, Amsterdam, p. 17.
Buckman, M. T., and Kellner R. (1985). Reduction of distress in hyperprolactinemia with bromocriptine.Am. J. Psychiat. 142: 242–244.
Buvat, J. (1982). Influence de l'hyperprolactinémie primaire sur le comportement sexuel humain.Nouv. Presse Med. 11: 3561–3563.
Campbell, S., and Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome.Clin. Obstet. Gynecol. 4: 31–47.
Carter, J. N., Tyson, J. E., Tolis, G., van Vliet, S., Faiman, C., and Friesen, H. (1978). Prolactin-secreting tumors and hypogonadism in 22 men.New Engl. J. Med. 299: 847–852.
Coope, J. J. (1976). Double blind cross-over study of estrogen replacement therapy. In Campbell, S. (ed.),The Management of the Menopause and Post-Menopausal Years University Park Press, Baltimore, pp. 159–168.
Cutler, W. B., Garcia, C-R., Huggins, G. R., and Preti, G. (1986). Sexual behavior and steroid levels among gynecologically mature premenopausal women.Fertil. Steril. 45: 496–502.
Davidson, J. M., Camargo, C. A., and Smith, E. R. (1979). Effects of androgen on sexual behavior in hypogonadal men.J. Clin. Endocrinol. Metab. 48: 955–958.
Fischer, P-A. (1963).Hypophysenadenome Ferdinand Enke Verlag, Stuttgart.
Franks, S., Jacobs., H. S., Martin, N., and Nabarro, J. D. N. (1978). Hyperprolactinemia and impotence.Clin. Endocrinol. 8: 277–287.
Fürst, E. (1966). On chromophobe pituitary adenomas.Acta Med. Scand. Suppl. 452: 1–111.
Gooren, L. J. G. (1987). Androgen levels and sex function in testosterone-treated hypogonadal men.Arch. Sex. Behav. 16: 463–473.
Heimbach, S. B. (1959). Follow-up studies on 105 cases of verified chromophobe and acidophile pituitary adenomata after treatment by transfrontal operation and x-ray irradiation.Acta Neurochir. 7: 101–155.
Hipkin, L. J., Diver, M. J., and Davis, J. C. (1986). The relationship between plasma prolactin and testosterone levels in male hypogonadism.J. Endocrinol. Invest. 9: 453–457.
Hulting, A. L., Muhr, C., Lundberg, P. O., and Werner, S. (1985). Prolactinomas in men: Clinical characteristics and the effect of bromocriptine treatment.Acta Med. Scand. 217: 101–109.
Lundberg, P. O., Drettner, B., Hemmingsson, A., Stenkvist, B., and Wide, L. (1977). The invasive pituitary adenoma. A prolactin-producing tumor.Arch. Neurol. 34: 742–749.
Lundberg, P. O., Muhr, C., Hulter, B., Brattberg, A., and Wide, L. (1986). Sexual libido in patients with hypothalamopituitary disorders. In Kothari, P. (ed.),Proceedings of the 7th World Congress of Sexology, New Delhi, pp. 126–128.
Lundberg, P. O., and Wide, L. (1978). Sexual function in males with pituitary tumors.Fertil. Steril. 29: 175–179.
Muhr, C., Hulting, A-L., Lundberg, P. O., and Werner, S. (1985). Pituitary adenomas with hyperprolactinemia in males. In Auer, L. M., Leb, L. G., Tscherne, G., Urdl, W., and Walter, G. F. (eds.),Prolactinomas. An Interdisciplinary Approach de Gruyter, New York, pp. 169–178.
Nagulesparen, M., Ang, V., and Jenkins, J. S. (1978). Bromocriptine treatment of males with pituitary tumours, hyperprolactinemia, and hypogonadism.Clin. Endocrinol. 9: 73–79.
Persky, H., Charney, N., Lief, H. I., O'Brien, C. P., Miller, W. R., and Strauss, D. (1978). The relationship of plasma estradiol level to sexual behavior in young women.Psychosom. Med. 40: 523–535.
Roeder, F., Müller, D., and Orthner, H. (1971). Weitere Erfahrungen mit der stereotaktischen Behandlung sexueller Perversionen.J. Neuro-Visceral Rel. Suppl. 10: 317–324.
Sherwin, B. (1985). Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women.Maturitas 7: 225–233.
Sherwin, B., Gelfand, M. M., and Brender, W. (1985). Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause.Psychosom. Med. 47: 339–351.
Wide, L. (1969). Radioimmunoassays employing immunosorbents.Acta Endocrinol. 142 (Suppl.): 207–221.
Younghusband, O. Z., Horrax, G., Hurxthal, L. M., Hare, H. F., and Poppen, J. L. (1952). Chromophobe pituitary tumors. I. Diagnosis.J. Clin. Endocrinol. Metab. 12: 611–630.
About this article
Cite this article
Hulter, B., Lundberg, P.O. Sexual function in women with hypothalamo-pituitary disorders. Arch Sex Behav 23, 171–183 (1994). https://doi.org/10.1007/BF01542097
- female sexuality
- hypothalamo-pituitary disorders